Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A National Strategy to Diagnose Coronavirus Disease 2019–Associated Invasive Fungal Disease in the Intensive Care Unit
P. Lewis White, Rishi Dhillon, Alan Cordey, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1634-e1644
Open Access | Times Cited: 414

Showing 26-50 of 414 citing articles:

Coronavirus Disease 2019–Associated Invasive Fungal Infection
John W. Baddley, George R. Thompson, Sharon C.‐A. Chen, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 12
Open Access | Times Cited: 98
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review
Francesco Vladimiro Segala, Davide Fiore Bavaro, Francesco Di Gennaro, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2110-2110
Open Access | Times Cited: 95
Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis
Hayato Mitaka, Toshiki Kuno, Hisato Takagi, et al.
Mycoses (2021) Vol. 64, Iss. 9, pp. 993-1001
Open Access | Times Cited: 91
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 921-921
Open Access | Times Cited: 82
Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019
José Yesid Rodríguez, Patrice Le Pape, Olga López del Moral López, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 9, pp. e2836-e2837
Open Access | Times Cited: 81
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
Stefan Hatzl, Alexander C. Reisinger, Florian Posch, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 79
A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19
Anubhav Kanwar, Alex Jordan, Scott Olewiler, et al.
Journal of Fungi (2021) Vol. 7, Iss. 3, pp. 174-174
Open Access | Times Cited: 78
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
Simon Feys, Maria Panagiota Almyroudi, Reinout Braspenning, et al.
Journal of Fungi (2021) Vol. 7, Iss. 12, pp. 1067-1067
Open Access | Times Cited: 77
COVID-19—Lessons Learned and Questions Remaining
Ferric C. Fang, Constance A. Benson, Carlos del Rı́o, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. 2225-2240
Open Access | Times Cited: 76
Invasive mould disease in fatal COVID-19: a systematic review of autopsies
Brittany Kula, Cornelius J. Clancy, M. Hong Nguyen, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 8, pp. e405-e414
Open Access | Times Cited: 76
Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs
Amir Arastehfar, Tahmineh Shaban, Hossein Zarrinfar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 4, pp. 280-280
Open Access | Times Cited: 74
Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches
Jeffrey D. Jenks, Hannah Nam, Martin Hoenigl
Mycoses (2021) Vol. 64, Iss. 9, pp. 1002-1014
Open Access | Times Cited: 73
COVID-19 Impairs Immune Response to Candida albicans
Dominique Moser, Katharina Biere, Bing Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion
Frank L. van de Veerdonk, Roger J. M. Brüggemann, Shoko Vos, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 7, pp. 795-802
Open Access | Times Cited: 70
A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study
Ekadashi Rajni, Ashutosh Singh, Bansidhar Tarai, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 12
Open Access | Times Cited: 70
Epidemiology and Mycology of Candidaemia in non‐oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non‐COVID‐19 and COVID‐19 cases
Precious Macauley, Oleg Epelbaum
Mycoses (2021) Vol. 64, Iss. 6, pp. 634-640
Open Access | Times Cited: 67
Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
Jochem B. Buil, Arthur R. H. van Zanten, Robbert G. Bentvelsen, et al.
Eurosurveillance (2021) Vol. 26, Iss. 23
Open Access | Times Cited: 66
Recent Trends in the Epidemiology of Fungal Infections
Emma E. Seagle, Samantha Williams, Tom Chiller
Infectious Disease Clinics of North America (2021) Vol. 35, Iss. 2, pp. 237-260
Open Access | Times Cited: 62
Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients
Jacopo Fumagalli, Mauro Panigada, Michael Klompas, et al.
Current Opinion in Critical Care (2021) Vol. 28, Iss. 1, pp. 74-82
Open Access | Times Cited: 62
Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
Frédéric Lamoth, Russell E. Lewis, Thomas J. Walsh, et al.
The Journal of Infectious Diseases (2021)
Open Access | Times Cited: 60
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance
Nathan P. Wiederhold
Clinical Chemistry (2021) Vol. 68, Iss. 1, pp. 83-90
Open Access | Times Cited: 58
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
Rasmus Leistner, Lisa Schroeter, Thomas C. Adam, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 56
COVID-19-Associated Pulmonary Aspergillosis (CAPA)
George Dimοpoulos, Maria Panagiota Almyroudi, Pavlos Myrianthefs, et al.
Journal of Intensive Medicine (2021) Vol. 1, Iss. 2, pp. 71-80
Open Access | Times Cited: 55
COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies
Nafisa Ahmed, Maiesha Samiha Mahmood, Md. Asad Ullah, et al.
Current Microbiology (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 55

Scroll to top